Alanis et al v. Pfizer Inc. et al
Filing
27
CONDITIONAL REMAND ORDER. MDL No. 2502. Case reopened. (Robles, S)
2:14-mn-02502-RMG
Date Filed 11/28/16
Entry Number 1752
Page 1 of 19
Case MDL No. 2502 Document 786 Filed 11/28/16 Page 1 of 3
A TRUE COPY
ATTEST: ROBIN L. BLUME, CLERK
BY:
DEPUTY CLERK
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION
IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)
MDL No. 2502
(SEE ATTACHED SCHEDULE)
CONDITIONAL REMAND ORDER
The transferee court in this litigation has advised the Panel that coordinated or consolidated pretrial
proceedings in the action(s) on this conditional remand order have been completed and that remand
to the transferor court(s), as provided in 28 U.S.C. § 1407(a), is appropriate.
IT IS THEREFORE ORDERED that the action(s) on this conditional remand order be remanded to
its/their respective transferor court(s).
IT IS ALSO ORDERED that, pursuant to Rule 10.2 of the Rules of Procedure of the United States
Judicial Panel on Multidistrict Litigation, the transmittal of this order to the transferee clerk for
filing shall be stayed 7 days from the date of this order. If any party files a notice of opposition with
the Clerk of the Panel within this 7−day period, the stay will be continued until further order of the
Panel. This order does not become effective until it is filed in the office of the Clerk for the United
States District Court for the District of South Carolina.
IT IS FURTHER ORDERED that, pursuant to Rule 10.4(a), the parties shall furnish the Clerk for
the District of South Carolina with a stipulation or designation of the contents of the record to be
remanded.
FOR THE PANEL:
Nov 28, 2016
Jeffery N. Lüthi
Clerk of the Panel
2:14-mn-02502-RMG
Date Filed 11/28/16
Entry Number 1752
Page 2 of 19
Case MDL No. 2502 Document 786 Filed 11/28/16 Page 2 of 3
IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)
MDL No. 2502
SCHEDULE FOR CRO
TRANSFEREE
DIST DIV. C.A.NO.
SC 2 14−02287
SC 2 14−02289
SC 2 14−02291
SC 2 14−02296
SC 2 14−02298
SC 2 14−02304
SC 2 14−02305
SC 2 14−02309
SC 2 14−02310
SC 2 14−02311
SC 2 14−02316
SC 2 14−02317
SC 2 14−02318
SC 2 14−02321
SC 2 14−02320
SC 2 14−02322
SC 2 14−02323
SC 2 14−02324
SC 2 14−02325
SC 2 14−02326
SC 2 14−02327
SC 2 14−02328
SC 2 14−02330
SC 2 14−02290
SC 2 14−02297
SC 2 14−02299
SC 2 14−02300
SC 2 14−02301
SC 2 14−02302
SC 2 14−02303
SC 2 14−02306
SC 2 14−02308
SC 2 14−02339
SC 2 14−02340
SC 2 14−02341
SC 2 14−02342
TRANSFEROR
DIST DIV. C.A.NO.
CAC 2 14−01800
CAC 2 14−01804
CAC 2 14−01806
CAC 2 14−01807
CAC 2 14−01811
CAC 2 14−01814
CAC 2 14−01815
CAC 2 14−01816
CAC 2 14−01818
CAC 2 14−01819
CAC 2 14−01820
CAC 2 14−01822
CAC 2 14−01823
CAC 2 14−01828
CAC 2 14−01829
CAC 2 14−01831
CAC 2 14−01832
CAC 2 14−01836
CAC 2 14−01837
CAC 2 14−01841
CAC 2 14−01843
CAC 2 14−01844
CAC 2 14−01848
CAC 2 14−01850
CAC 2 14−01853
CAC 2 14−01854
CAC 2 14−01857
CAC 2 14−01858
CAC 2 14−01860
CAC 2 14−01861
CAC 2 14−01862
CAC 2 14−01863
CAC 2 14−01866
CAC 2 14−01867
CAC 2 14−01869
CAC 2 14−01872
CASE CAPTION
Pamela McKenzie et al v. Pfizer,Inc et al
Juana Garcia et al v. Pfizer Inc et al
Bernadette Fernandez et al v. Pfizer, Inc. et al
Segalilt Siegel et al v. Pfizer, Inc. et al
Bonnie Kessner et al v. Pfizer Inc et al
Deberah Rivington et al v. Pfizer Inc et al
Phyllis Beima et al v. Pfizer Inc et al
Nina Obuch et al v. Pfizer Inc et al
Alida Adamyan et al v. Pfizer, Inc
Maria Carbajal et al v. Pfizer Inc et al
Dorothy M. Andres et al v. Pfizer, Inc. et al
Donna Kruenegel et al v. Pfizer, Inc. et al
Mattie King et al v. Pfizer, Inc.
Rose A. Williams et al v. Pfizer, Inc. et al
Vicky Avila et al v. Pfizer, Inc.
Maizy Benons et al v. Pfizer, Inc. et al
Linda Roy et al v. Pfizer, Inc. et al
Brenda Johnson et al v. Pfizer Inc et al
Blanca Mejia et al v. Pfizer Inc et al
Lori Ann Weisman et al v. Pfizer Inc et al
Sylvia Alvardo v. Pfizer Inc et al
Lena Whitaker et al v. Pfizer Inc et al
Patricia Lewis et al v. Pfizer, Inc. et al
Emma Frields et al v. Pfizer, Inc. et al
Fiette Williams et al v. Pfizer, Inc. et al
Pallavi Mehta et al v. Pfizer, Inc. et al
Theresa Medina et al v. Pfizer, Inc. et al
Deborah McClain et al v. Pfizer Inc et al
Valerie Davis v. Pfizer Inc et al
Tonisha Powell et al v. Pfizer Inc et al
Zurita Gray et al v. Pfizer, Inc. et al
Clara Bagdasarian et al v. Pfizer, Inc. et al
Deloris Ann Richard et al v. Pfizer Inc et al
Mazal Azzam et al v. Pfizer, Inc. et al
Imelda Diaz et al v. Pfizer Inc et al
Shahla Owhady et al v. Pfizer Inc et al
2:14-mn-02502-RMG
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
Date Filed 11/28/16
Entry Number 1752
Page 3 of 19
Case MDL No. 2502 Document 786 Filed 11/28/16 Page 3 of 3
2 14−02343 CAC 2 14−01874 Ouida Valentine et al v. Pfizer Inc et al
2 14−02344 CAC 2 14−01876 Loretta Curley et al v. Pfizer Inc et al
2 14−02345 CAC 2 14−01889 Regina Feberdino et al v. Pfizer Inc et al
2 14−02346 CAC 2 14−01892 Ruth English et al v. Pfizer Inc et al
2 14−02349 CAC 2 14−01894 Cheri Lubenko v. Pfizer Inc et al
2 14−02350 CAC 2 14−01895 Jessie Hill et al v. Pfizer Inc et al
2 14−02351 CAC 2 14−01896 Doris Choate et al v. Pfizer Inc et al
2 14−02352 CAC 2 14−01897 Susan Kelley et al v. Pfizer Inc et al
2 14−02353 CAC 2 14−01898 Charlene Tate et al v. Pfizer Inc et al
2 14−02354 CAC 2 14−01899 Mary Adamian et al v. Pfizer Inc et al
2 14−02355 CAC 2 14−01904 Candacy Roberts−Anderson et al v. Pfizer, Inc.
et al
2 14−02356 CAC 2 14−01906 Louise Harris et al v. Pfizer Inc et al
2 14−02357 CAC 2 14−01907 Shirley Reynolds et al v. Pfizer Inc et al
2 14−02358 CAC 2 14−01908 Juanita Banks et al v. Pfizer Inc
2 14−02359 CAC 2 14−01910 Ruby Hare et al v. Pfizer Inc et al
2 14−02361 CAC 2 14−01912 Janice S. Robinson et al v. Pfizer Inc et al
2 14−02362 CAC 2 14−01914 Joy Zullo et al v. Pfizer Inc et al
2 14−02364 CAC 2 14−01921 Frankie Brown et al v. Pfizer Inc et al
2 14−02365 CAC 2 14−01924 Jocelyn Clemente Salvo et al v. Pfizer Inc et al
2 14−02366 CAC 2 14−01925 Gladys Anderson et al v. Pfizer Inc et al
2 14−02370 CAC 2 14−01928 Darlene Jordan et al v. Pfizer Inc et al
2 14−02372 CAC 2 14−01930 Denelle Bailey et al v. Pfizer Inc et al
2 14−02373 CAC 2 14−01931 Edith Wakabayashi v. Pfizer Inc et al
2 14−02374 CAC 2 14−01932 Maye Alberstone et al v. Pfizer Inc et al
2 14−02376 CAC 2 14−01937 Marilyn Williams et al v. Pfizer, Inc. et al
2 14−02377 CAC 2 14−01940 Linda Franzone et al v. Pfizer Inc et al
2 14−02379 CAC 2 14−01943 Tomie Isrel et al v. Pfizer Inc et al
2 14−02380 CAC 2 14−01997 Elizabeth Ann Watts et al v. Pfizer Inc et al
2 14−02273 CAC 5 14−00485 Alma Richards v. Pfizer Inc et al
2 14−01810 CAC 5 14−00493 Chasa Williams v. Pfizer Inc et al
2 14−02274 CAC 5 14−00496 Sharon Parker et al v. Pfizer Inc et al
2 14−02231 CAE 1 14−00365 Alanis et al v. Pfizer Inc. et al
2 14−02263 CAN 3 14−01177 Little et al v. Pfizer Inc.
2 14−02257 CAN 3 14−01195 Rouda v. Pfizer Inc., et al
2 14−02256 CAN 3 14−01196 Peters v. Pfizer Inc. et al
2 14−02241 CAN 3 14−01204 Kathleen Davis v. Pfizer Inc.
2:14-mn-02502-RMG
Date Filed 11/28/16
Entry Number 1752
Page 4 of 19
2:14-mn-02502-RMG Date Filed 11/07/16 Entry Number 1726 Page 1 of 16
Case MDL No. 2502 Document 786-1 Filed 11/28/16 Page 1 of 16
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF SOUTH CAROLINA
=
;;:;
~ ~
::0::0
...:
•
IN RE: LlPITOR (ATORVASTATIN
CALCIUM) MARKETING, SALES
PRACTICES AND PRODUCTS
LIABILITY LITIGATION
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
......
MDL No. 2: 14-mn-02502-RMG
55
0
(")
>
::em
.(")
1t~
~~
:z
~o
\Q
(I)
CASE MANAGEMENT ORDER N
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?